IRIS NEOVASCULARISATION

IRIS NEOVASCULARISATION was reported 125 times

IRIS NEOVASCULARISATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Photoenhancer [EPC] 2 0.0005
1 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0003
2 Carbonic Anhydrase Inhibitor [EPC] 6 0.0003
3 Antiseptic [EPC] 1 0.0002
4 Recombinant Human Nerve Growth Factor [EPC] 3 0.0002
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 35 0.0002
6 Complement Inhibitor [EPC] 10 0.0002
7 Provitamin D2 Compound [EPC] 4 0.0001
8 Anticholinergic [EPC] 2 0.0001
9 Prostaglandin Analog [EPC] 10 0.0001
10 Lipid-based Polyene Antifungal [EPC] 1 0.0001
11 Melatonin Receptor Agonist [EPC] 1 0.0001
12 Ester Local Anesthetic [EPC] 3 0.0001
13 Nucleoside Analog Antiviral [EPC] 5 0.0001
14 Cholinergic Muscarinic Antagonist [EPC] 2 0.0001
15 Glycopeptide Antibacterial [EPC] 3 0.0000
16 Platinum-based Drug [EPC] 12 0.0000
17 Insulin [EPC] 2 0.0000
18 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
19 Aluminum Complex [EPC] 1 0.0000
20 Sulfonylurea [EPC] 5 0.0000
21 Copper-containing Intrauterine Device [EPC] 2 0.0000
22 Radiographic Contrast Agent [EPC] 1 0.0000
23 Topoisomerase Inhibitor [EPC] 2 0.0000
24 Non-Standardized Chemical Allergen [EPC] 2 0.0000
25 Polyene Antifungal [EPC] 1 0.0000
26 Thiazide-like Diuretic [EPC] 1 0.0000
27 Amide Local Anesthetic [EPC] 2 0.0000
28 Aminoglycoside Antibacterial [EPC] 1 0.0000
29 Phosphodiesterase 5 Inhibitor [EPC] 3 0.0000
30 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
31 beta3-Adrenergic Agonist [EPC] 1 0.0000
32 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
33 Antiarrhythmic [EPC] 2 0.0000
34 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
35 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
36 Insulin Analog [EPC] 7 0.0000
37 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
38 Corticosteroid [EPC] 18 0.0000
39 Arteriolar Vasodilator [EPC] 1 0.0000
40 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
41 Catecholamine [EPC] 1 0.0000
42 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
43 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
44 Osmotic Laxative [EPC] 3 0.0000
45 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
46 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
47 Proteasome Inhibitor [EPC] 1 0.0000
48 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
49 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
50 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
51 Alkylating Drug [EPC] 2 0.0000
52 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
53 Nonsteroidal Anti-inflammatory Drug [EPC] 10 0.0000
54 Factor Xa Inhibitor [EPC] 2 0.0000
55 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
56 Leukocyte Growth Factor [EPC] 1 0.0000
57 Platelet Aggregation Inhibitor [EPC] 4 0.0000
58 Calcium [EPC] 1 0.0000
59 Vitamin D [EPC] 2 0.0000
60 Loop Diuretic [EPC] 3 0.0000
61 Azole Antifungal [EPC] 1 0.0000
62 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
63 Estrogen [EPC] 1 0.0000
64 Proton Pump Inhibitor [EPC] 3 0.0000
65 Vitamin C [EPC] 2 0.0000
66 GLP-1 Receptor Agonist [EPC] 2 0.0000
67 Thalidomide Analog [EPC] 2 0.0000
68 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
69 beta-Adrenergic Blocker [EPC] 1 0.0000
70 Vitamin B12 [EPC] 1 0.0000
71 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
72 Tumor Necrosis Factor Blocker [EPC] 1 0.0000